Atlas Trials

Neoadjuvant Lymph Node Targeted Immunotherapy in Cervical Cancer: a Feasibility Study (NEOLYNC)

Clinical trial NCT07653503 · RECRUITING

Trial details

NCT number
NCT07653503
Sponsor
University Medical Center Groningen
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Cervical Carcinoma
Start date
2026-01-05
Primary completion
2027-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.